Company ProfilePremium

Anand Rayons Limited

Company Profile Analysis

Ticker: 542721.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Anand Rayons Limited - Company showcase

Year Founded & Workforce

1987

Anand Rayons Limited logo

Anand Rayons Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Anand Rayons Limited Overview

FieldDetailSource
Legal nameAnand Rayons LimitedBSE filings; MCA
Former names / predecessorM/s Anand Enterprise (partnership firm, est. 1 July 1987); converted to public limited company 20 September 2018IIFL company summary (from DRHP)
Founding year1987 (partnership); incorporated as company 2018DRHP via IIFL; Simply Wall St
Certificate of Incorporation2 October 2018 (conversion effective 20 September 2018)DRHP via IIFL
CINL51909GJ2018PLC104200RegisterKaro (MCA data)
Incorporation jurisdictionGujarat, India; Registrar of Companies, AhmedabadRegisterKaro
Registered office / HQ305-306, Jay Sagar Complex, Opp. Sub Jail, Surat, Gujarat 395002, IndiaSimply Wall St; BSE filings
Exchange / tickerBSE Limited — Scrip 542721, Symbol ARL (not listed on NSE)BSE; MarketsMojo
Listing dateJuly 2019 (IPO allotment 2 July 2019)Simply Wall St; MarketsMojo capital history
ISININE02GA01012MarketsMojo; FinancialFilings
LEI335800FAGKR4XYASNE09FinancialFilings
CUSIPNot applicable (no US listing)—
Face value₹10 per shareScreener
Shares outstanding≈2.19 crore (derived: market cap ₹76.7 Cr ÷ price ₹35.0, Oct 2026); 2.147 crore reported Feb 2026 prior to July 2026 warrant conversionScreener; Simply Wall St
Fiscal year end31 MarchAnnual reports
EmployeesNot publicly disclosed in sources reviewed (Screener's extracted employee count is paywalled; not stated in aggregator data)—
Statutory auditorM/s M. R. Bombaywala & Co., Chartered Accountants (unmodified opinion on FY2026 results)FY2026 results (BSE, 22 May 2026)
Internal auditorM/s Sutarwala & Associates, Chartered Accountants, Surat (re-appointed for FY2027)FY2026 board outcome
Company Secretary & Compliance OfficerMrs. Varsha MaheshwariBSE filings (2023–2026)
Market capitalisation (current)≈₹76.7 Cr at ₹35.0 (15 Oct 2026)Screener
Websitewww.anandrayons.comCompany
Industry classificationConsumer Discretionary › Textiles › Textiles & Apparels › Trading – Textile Products; NIC 51909 (wholesale trade)Screener; RegisterKaro

The listing details supplied (Country: India; Exchange: BSE; Ticker: ARL.BO) correspond to Anand Rayons Limited, BSE scrip code 542721, BSE trading symbol ARL, Reuters RIC ANAY.BO. The entity has not changed its name since conversion to a company in 2018 and remains listed on BSE.

Anand Rayons Limited is a Surat-based, promoter-controlled trader and distributor of synthetic and value-added yarns — principally polyester, nylon, viscose, embroidery and dyed yarns, and zari/core yarns — serving weavers, embroiderers, zari manufacturers and garment converters concentrated in Gujarat's synthetic-textile cluster and other Indian textile hubs. Operating since 1987 as a dealership-led wholesaler that historically represented mills such as JCT, Indorama Synthetics, Garden Silk and Filatex (Philatex), the company runs an asset-light, working-capital-intensive model with gross margins near 4% and operating margins of roughly 2–2.5%. FY2026 revenue reached a record ₹433 Cr with net profit of ₹7.25 Cr, funded in part by a ₹54 Cr preferential-warrant equity raise that de-levered the balance sheet. Management has signalled diversification into petrochemical oils, aluminium-foil packaging and food, but the business remains effectively a single-segment domestic textile trading house. Its equity has fallen ~92% from its ₹470 peak despite rising earnings.


What the company does

Anand Rayons is a trading and distribution business in man-made fibre (MMF) yarns. It purchases yarn in bulk from spinning/polymerisation mills (historically as an authorised dealer) and resells to downstream textile units — weavers producing sarees, shirting and dress material; embroidery units; yarn dyers; zari (metallic thread) manufacturers; carpet makers; narrow-fabric/elastic-tape producers; and sizing units. The company's own historical description (from its 2019 DRHP, as summarised by IIFL) emphasises trading in value-added yarns such as doped-dyed yarns and fancy yarns, a strong market share in embroidery and dyed yarn locally, and the supply of core yarn in value-added form to zari manufacturers.

The company's filings classify it in a single reportable segment — textiles/trading. The Q1 FY2026 results described the trading division as constituting the entirety of operations (ScanX digest of BSE filing, August 2025), and the Q2 FY2026 results reiterated that the company operates solely in the textile segment.

Company's own characterisation (latest available)

The company's annual-report business overview (FY2024 report, as extracted by Screener) describes Anand Rayons as part of the "Anand Group", specialising in embroidery yarn, dyed yarn, and fabric manufacturing for T-shirts, garments and apparel. The same report states the company had diversified into petrochemical products — yellow oil, white oil, base oil and palm oil, primarily for adhesive industries — planned to export chemicals internationally, and had ventured into packaging by importing aluminium foil and other packaging products. Screener's corporate summary describes the business as "manufacturing and trading of yarn & fabrics", though no manufacturing fixed assets of consequence appear on the balance sheet (fixed assets ≈₹1 Cr at March 2026), which suggests any "manufacturing" is outsourced/job-work based.

Business model and revenue model

DimensionCharacterisationEvidence
Product vs. service mix~100% product sales (traded goods); no disclosed service, subscription or licensing revenueSingle trading segment in results
Value-chain positionMid-stream intermediary between yarn producers (polymer/spinning mills) and fragmented downstream weaving/embroidery/zari unitsDRHP history; AR FY2024
Gross margin≈4.7% (Simply Wall St TTM gross profit ₹18.8 Cr on revenue ₹401 Cr, data to Dec 2025)Simply Wall St
Operating margin (OPM)1.4%–2.5% range across FY2020–FY2026Screener
Capital intensityVery low fixed assets (≈₹1 Cr); balance sheet is >95% current assets (receivables, inventory, cash)Screener balance sheet
Working-capital profileDebtor days 73, inventory days 7, payable days 3 → cash conversion cycle 77 days (FY2026)Screener ratios
Credit roleEffectively extends trade credit to small downstream units while paying suppliers quickly — a financing function embedded in the trading marginDebtor vs payable days
Customer typesMSME weavers, embroiderers, zari makers, yarn dyers, carpet and elastic-tape makers, sizing unitsDRHP via IIFL
End-marketsDomestic Indian apparel, ethnic wear (sarees, dress material), home textiles (carpets), narrow fabricsDRHP via IIFL; Zonebourse description
GeographyDomestic India only; historically Surat, later Ahmedabad, Vapi, Daman, Varanasi, Ichalkaranji, Bengaluru, Erode, CoimbatoreDRHP via IIFL

Independent characterisation

In substance, Anand Rayons is a thin-margin, high-turnover working-capital business whose economic value derives from (a) supplier relationships and dealership access in a commoditised market, (b) credit underwriting of small textile units, and (c) inventory/price-risk management in yarns whose prices track crude-oil-linked feedstocks (PTA, MEG, caprolactam). Return on equity has historically been modest (5-year average ≈8% per Screener) because each rupee of profit requires substantial receivables financing. The FY2025–FY2026 preferential equity raise transformed the balance sheet from a 1:1 debt-to-equity structure to ~0.35x and enabled the 38% revenue jump in FY2026, but it also diluted ROE. The announced diversification initiatives (petrochemical oils, aluminium foil, food partnership) have not been reported as separate segments, and their revenue contribution is not publicly disclosed.

Strategy

Stated corporate strategy

Anand Rayons does not publish an investor presentation, hold earnings calls or host investor days, so strategy must be inferred from annual-report narrative and exchange disclosures. Themes discernible from the FY2024 annual report and subsequent filings:

  1. Core franchise in value-added yarns — maintaining position in embroidery, dyed and zari-core yarns where the company claims local market share.

  2. Adjacent-commodity diversification — trading petrochemical oils (yellow, white, base, palm oil) for adhesive makers, leveraging the same B2B trading competence.

  3. International expansion — stated plan to export chemicals.

  4. Packaging — import and distribution of aluminium foil and packaging products.

  5. Food sector entry — five-year partnership with Chhabee Nutricos Inds LLP (announced August 2025), framed by the company as a response to growth opportunities and rising consumer demand in food and beverages, and as a means of reducing dependence on a single sector.

  6. Balance-sheet strengthening — the ₹69 Cr (potential) preferential warrant programme approved January 2025 to fund working capital and growth.

Strategic initiatives register (last 24 months)

DateInitiativeTypeStatus / outcome
8 Jan 2025Shareholder approval for preferential warrant issueCapital raiseApproved
19 Feb 2025Allotment of 88.62 lakh warrants at ₹78Capital raise≈78% converted; 19.38 lakh lapsed 28 Sep 2026
Feb 2025 – Jul 2026Successive warrant conversions (22 Feb 2025, 24 May 2025, 9 Jun 2025, 23 Jul 2025, 17 Jan 2026, 20 Jul 2026)Capital raise≈₹54 Cr received (derived)
Aug 2025Chhabee Nutricos Inds LLP partnership (food)New businessRevenue contribution not disclosed; no separate segment
31 Aug 2026₹10 Cr increase in authorised capitalCapital structureSignals potential future equity issuance; purpose not disclosed
FY2024 onwardPetrochemical oils and aluminium-foil tradingDiversificationRevenue contribution not disclosed

Cost programmes, ESG commitments and medium-term targets

Cost programmes: none announced. The Q3 FY2026 digest refers generically to cost management yielding results, without quantification.

ESG/sustainability commitments: none disclosed.

Medium-term financial targets / guidance: not publicly disclosed. Management provides no revenue, margin or return guidance.

Products & Services

All products sit within the single textile/trading segment. The company does not publish SKU-level specifications, launch years or pricing; it trades third-party mill brands. Pricing is market-linked (spot/contract yarn prices) and not publicly disclosed.

Flagship offerings: No proprietary brands are disclosed. The commercially significant lines, based on management's own historical emphasis, are embroidery yarn, dyed yarn, and core yarn for zari.

Product Portfolio

#Product lineDescription & key specificationsTarget customerOrigin / yearPricing model
1

Polyester yarn

Synthetic filament yarn based on PET (from PTA and MEG); traded forms per industry norms include POY, FDY and DTY

Weavers (sarees, shirting, dress material), knitters

Core line since dealership era (Indorama Synthetics, Garden Silk, Filatex)

Market-linked; not disclosed

2

Nylon yarn

Available as nylon POY, FDY, DTY and dyed nylon yarn; applications include fabrics, bridal veils, carpets, ropes

Weavers, carpet makers, technical/narrow-fabric units

Dealership of JCT Limited historically

Market-linked; not disclosed

3

Embroidery yarn

Value-added filament yarn for machine embroidery; company claims a "decent market share" locally

Surat embroidery units

Long-standing line

—
4

Dyed yarn / doped-dyed yarn

Pre-coloured yarns (dope-dyed at polymer stage or package-dyed)

Weavers, embroiderers seeking colour-fast yarn

Long-standing value-added line

—
5

Zari / core yarn

Core yarn supplied in value-added form to zari (metallic thread) manufacturers; zari itself also traded

Zari manufacturers (Surat is a major zari centre)

Long-standing

—
6

Viscose (rayon) yarn

Cellulosic yarn (the company's name derives from rayon)

Weavers of ethnic wear and dress material

Long-standing

—
7

Fancy yarns

Novelty/effect yarns for sarees, dress materials

Weavers

Value-added line

—
8

Yarns for elastic tapes & sizing

Yarns for narrow fabrics and sizing segment

Elastic-tape makers, sizing units

Value-added line

—
9

Carpet yarns

Yarns for carpet manufacturing

Carpet makers

Value-added line

—
10

Fabrics (T-shirt/apparel)

Fabric "manufacturing" for T-shirts, garments, apparel (likely via job-work given negligible fixed assets)

Garment makers

Disclosed in AR FY2024

—
11

Petrochemical oils

Yellow oil, white oil, base oil, palm oil — primarily for adhesive industries

Adhesive manufacturers

Disclosed in AR FY2024

—
12

Chemicals (export)

Plan to export chemicals internationally

Overseas buyers

Planned (AR FY2024); no export revenue disclosed

—
13

Aluminium foil & packaging

Imported aluminium foil and other packaging products

Packaging users

Disclosed in AR FY2024

—
14

Food products (via partnership)

Food-sector business with Chhabee Nutricos Inds LLP (5-year arrangement)

Food & beverage market

Announced Aug 2025

—

“—” = not publicly disclosed.

Financial Narrative

Income statement (FY2022–FY2026), ₹ Cr unless stated

Source: Screener (C-MOTS data from BSE filings); FY2024–FY2026 line items aggregated from quarterly BSE results; FY2026 PBT/PAT from company-reported audited results (22 May 2026). FY2022–FY2023 figures are rounded to the nearest crore in the source and are reconstructed from margins/EPS where stated.

Notes:

  • Gross profit is not separately reported in quarterly formats; Simply Wall St (S&P data) shows TTM gross profit of ₹18.8 Cr on revenue of ₹401 Cr for the twelve months to December 2025 (gross margin ≈4.7%). Annual gross profit by year is not publicly disclosed in the sources reviewed.

  • EBITDA here equals operating profit before other income (Screener definition). EBITDA including other income for FY2026 = ₹12.39 Cr.

  • FY2022 and FY2023 net profit derived as EPS × 1.498 Cr shares (shares outstanding in those years).

  • Screener lists FY2026 EPS as ₹3.38; the company-reported basic EPS is ₹3.36. The difference reflects weighted-share computation; company figure preferred.

Revenue CAGR FY2022–FY2026: ≈6.7%: (derived: (432.96/334)^(1/4) − 1). Screener's 5-year sales CAGR (to TTM) is 16% because FY2021 (₹207 Cr, COVID trough) is the base.

Net profit CAGR FY2022–FY2026: ≈25.3%: (derived: (7.25/2.94)^(1/4) − 1).

Commentary — income statement. The five-year record divides into two regimes. From FY2022 to FY2025, revenue was essentially flat at ₹314–344 Cr and net profit stuck at ₹2.9–3.5 Cr, with margins pinned in a 2.1–2.4% operating band — the signature of a commoditised trading book constrained by balance-sheet capacity (borrowings of ₹29–34 Cr against net worth of ₹30–36 Cr). FY2025 saw an 8.9% revenue decline, consistent with weak synthetic-textile demand and yarn-price deflation that year, yet net profit still edged up 11% due to better gross realisation (OPM 2.4%) and lower interest cost.

FY2026 marks a clear inflection: revenue jumped 38% to a record ₹433 Cr and net profit more than doubled to ₹7.25 Cr. Three drivers are visible in the numbers. First, balance-sheet capacity: warrant-conversion proceeds raised net worth from ₹36 Cr (March 2024) to ₹102 Cr (March 2026), allowing a larger receivables book. Second, other income rose from ₹0.10 Cr to ₹2.37 Cr — likely treasury income on cash parked from equity raises — contributing roughly a quarter of FY2026 pre-tax profit. Third, lower finance cost (₹2.31 Cr vs ₹2.65 Cr) despite a much larger revenue base. Core operating margin did not expand (2.31% vs 2.40%), meaning the profit surge was volume- and financing-driven rather than a structural margin improvement.

Quarterly income statement (Q1 FY2025 – Q1 FY2027), ₹ Cr

Source: Screener (BSE quarterly results). Quarterly results show 0% tax; the company books income tax at the year-end, so quarterly "net profit" equals pre-tax profit.

Commentary — quarterly. Five consecutive quarters of positive YoY revenue growth (Q1 FY2026–Q1 FY2027) have followed four quarters of decline. Q3 FY2026 was exceptional (OPM 3.81%, PBT ₹4.50 Cr — 46% of full-year FY2026 PBT in one quarter), which raises the question of whether a one-off trade or inventory gain inflated the quarter; no explanation is publicly disclosed. Q2 FY2026's EBITDA margin compressed to 1.22% from 2.44% a year earlier (ScanX digest), showing that the volume ramp initially came at lower unit margins. Q1 FY2027 (revenue ₹95.6 Cr, PBT ₹2.32 Cr) shows growth continuing but decelerating to 26% YoY and a sequential revenue decline of 19% from Q4 FY2026.

Analytical warning on TTM P/E. Aggregators compute TTM net profit of ≈₹10.9 Cr by summing quarterly figures that are in fact pre-tax. Applying the FY2026 effective rate (25.5%) gives normalised TTM PAT of ≈₹8.1 Cr (derived). Reported TTM P/E of ~7x therefore understates the true multiple; on normalised earnings it is ≈9.5x.

Balance sheet (31 March), ₹ Cr

Source: Screener (BSE annual reports). Rounded to nearest crore in source.

Additional data points:

Net debt, March 2026: ₹1.95 Cr: (Zerodha/aggregator), implying cash and equivalents of roughly ₹34 Cr against ₹36 Cr of borrowings. This is consistent with cumulative positive net cash flows of ₹5 Cr, ₹10 Cr, ₹9 Cr and ₹10 Cr in FY2023–FY2026 (Screener). Cash balances for earlier years are not separately extracted in sources reviewed.

Short- vs long-term debt split: not publicly disclosed in sources reviewed; given the trading model and absence of fixed assets, borrowings are presumed predominantly working-capital (short-term) facilities. RegisterKaro reports no open MCA-registered charges, which is unusual for bank working-capital lines and warrants verification against the FY2026 annual report.

Half-year balance sheet (30 Sep 2025): total assets ₹150.48 Cr; shareholders' funds ₹96.62 Cr; current assets ₹147.09 Cr (vs ₹96.58 Cr at March 2025) (ScanX digest of BSE filing).

FY2026 per FinancialFilings: total assets INR 1.53 billion; total equity INR 1.02 billion; cash from operations INR −112.81 million — consistent with Screener.

Working capital: current assets ≈₹150 Cr less current liabilities (other liabilities ₹15 Cr plus short-term borrowings of up to ₹36 Cr) implies net working capital of roughly ₹100 Cr at March 2026 (derived; exact current-liability split not disclosed in sources reviewed).

Book value per share: ₹47.6 (Screener, latest).

Commentary — balance sheet. Total assets doubled from ₹74 Cr to ₹153 Cr in two years, funded almost entirely by equity (net worth +₹66 Cr) rather than debt. The equity build reconciles closely with warrant economics: ≈69.24 lakh warrants converted at ₹78 (≈₹54 Cr, derived from 88.62 lakh allotted less 19.38 lakh lapsed), plus retained earnings of ≈₹10.7 Cr over FY2025–FY2026, plus the ₹3.78 Cr forfeiture credited after the September 2026 lapse (post-period). Borrowings dipped to ₹16 Cr in FY2025 as early conversion money repaid debt, then rose back to ₹36 Cr in FY2026 as the business scaled. The balance sheet is now conservatively geared, but its quality depends almost entirely on the collectability of trade receivables (73 debtor days on ₹433 Cr revenue ≈ ₹87 Cr of receivables — derived).

Cash flow statement, ₹ Cr

Source: Screener.

Commentary — cash flow. FY2022–FY2025 showed strong cash conversion (CFO exceeding EBITDA) as the company harvested working capital. FY2026 reversed sharply: operating cash flow of −₹11 Cr despite record profit, because receivables and other current assets absorbed the growth. The investing outflows of ₹24 Cr (FY2025) and ₹14 Cr (FY2026) are large relative to capex of ₹1–3 Cr; they most likely reflect deployment of equity proceeds into deposits/treasury instruments (consistent with rising other income), though the breakdown is not disclosed in sources reviewed. Financing inflows of ₹22 Cr and ₹36 Cr reflect warrant conversions and, in FY2026, a re-increase in borrowings. The business has never bought back shares and has paid a dividend only once (FY2019).

Ratio analysis

Source: Screener for ROCE and working-capital days; other ratios derived from the tables above (average-balance basis where noted).

Additional ratios:

Net debt / EBITDA (FY2026): ≈0.2x (₹1.95 Cr ÷ ₹10.02 Cr; derived).

ROIC: not separately computed by sources; given negligible fixed assets, ROIC approximates ROCE (≈10% FY2026).

Current ratio: not publicly disclosed in sources reviewed; with current assets ≈₹150 Cr and total non-equity liabilities ≈₹51 Cr, the current ratio is at least ~2.9x (derived upper-bound proxy).

Commentary — ratios. Return metrics are structurally capped by the trading model: ROE around 8–10% with a sub-1% net margin offset by 3.4–4.6x asset turnover. The FY2025 ROE trough (6.2%) is a dilution artefact — equity doubled before the incremental capital could be deployed. Interest coverage has improved markedly (5.2x), and leverage is now low. The most important adverse trend is in working capital: debtor days have risen from 44 (FY2024) to 73 (FY2026), and payable days have fallen to just 3, meaning Anand Rayons is financing both its customers and, effectively, prepaying suppliers. This is the mechanism by which the FY2026 growth consumed cash, and it is the key credit risk to monitor.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Income Statement and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Revenue from operations (INR Cr)

334336344.26313.75432.96

Revenue YoY growth (%)

61.40.62.5-8.938.0

Operating profit / EBITDA excl. other income (INR Cr)

8.07.17.277.5310.02

Other income (INR Cr)

000.070.102.37

Interest expense (INR Cr)

432.882.652.31

Depreciation (INR Cr)

000.220.320.36

Profit before tax (INR Cr)

444.244.659.73

Tax rate (%)

2926262525

Net profit (INR Cr)

2.943.153.133.477.25

EPS basic (INR)

1.962.102.091.893.36

Dividend per share (INR)

00000

Operating (EBITDA) margin (%)

2.42.12.12.42.3

Pre-tax margin (%)

1.21.21.21.52.2

Net margin (%)

0.880.940.911.111.67

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Margin Analysis (%) (Quarterly)

MetricQ1FY25Q2FY25Q3FY25Q4FY25Q1FY26Q2FY26Q3FY26Q4FY26Q1FY27

Revenue (INR Cr)

70.3182.9574.6485.8575.95112.25126.66118.1095.58

Revenue YoY (%)

-5.7-1.9-17.6-9.28.035.369.737.625.8

Operating profit (INR Cr)

0.922.021.752.841.131.354.822.722.25

OPM (%)

1.312.442.343.311.491.203.812.302.35

Other income (INR Cr)

0.000.010.000.090.310.650.610.800.67

Interest (INR Cr)

0.340.900.810.600.180.410.840.880.54

PBT (INR Cr)

0.521.070.822.251.171.504.502.552.32

EPS (₹, pre-tax basis)

0.350.710.541.220.560.702.111.191.08

Balance Sheet

MetricFY2022FY2023FY2024FY2025FY2026

Equity share capital (INR Cr)

1515151821

Reserves (INR Cr)

1518215881

Total equity / net worth (INR Cr)

30333676102

Borrowings (INR Cr)

3134291636

Other liabilities (INR Cr)

1899615

Total assets (INR Cr)

79767499153

Fixed assets (INR Cr)

00111

Capital work in progress (INR Cr)

00002

Goodwill & intangibles (INR Cr)

00000

Other (mainly current) assets (INR Cr)

79767398150

Cash Flow and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Cash from operating activities (INR Cr)

971611-11

Cash from investing activities (INR Cr)

0-22-24-14

Cash from financing activities (INR Cr)

-90-82236

Net cash flow (INR Cr)

0510910

Free cash flow (INR Cr)

971610-14

Capex (INR Cr, derived CFO − FCF)

00013

Dividends paid (INR Cr)

00000

Buybacks (INR Cr)

00000

CFO / EBITDA (%)

123117239165-88

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025FY2026

ROE (%, PAT / avg equity)

10.310.09.16.28.1

ROA (%, PAT / avg assets)

4.04.14.24.05.8

ROCE (%, Screener)

131111910

Debt / equity (x)

1.031.030.810.210.35

Interest coverage (EBIT / interest, x)

2.02.32.52.85.2

Asset turnover (sales / avg assets, x)

4.54.34.63.63.4

Debtor days

6758445773

Inventory days

877177

Payable days

188853

Cash conversion cycle (days)

5757446977

Working capital days

4038266454

Revenue by Region and Revenue by Region (%)

RegionFY2024FY2025FY2026

India revenue (INR Cr)

344.26313.75432.96

Outside India revenue (INR Cr)

000

India share of revenue (%)

100100100

India revenue YoY growth (%)

2.5-8.938.0

Share Price History

DatePrice (INR)Market cap (INR Cr)Note

Jul 2019

≈27

≈40

IPO price (implied)

7 Jan 2025

166.05—

Upper circuit; 52-week range ₹36.37–166.05

28 Mar 2025

200.50299.77

+299% over prior 6 months

1 Aug 2025

294.20

≈620

P/E ≈117x (Screener at the time)

9 Sep 2025

—794.13

Choice India

Late 2025 / Jan 2026

470.00—

All-time/52-week high (date unconfirmed)

20 Jan 2026

388.00828.10

Choice India

11 Feb 2026

208.25470.62

Upstox

6 Mar 2026

91.95

≈197

−62% in 1 month (Simply Wall St)

2 Apr 2026

63.43

≈136

ICICIdirect

30 Apr 2026

57.73124

Value Research

1 Jun 2026

47.72—

Value Research

7 Aug 2026

42.71

≈91

5paisa

2 Sep 2026

41.67—

Anand Rathi

6 Oct 2026

33.00

≈72

52-week low (MarketsMojo)

15 Oct 2026

35.0076.7

Screener

Share Price & Returns

HorizonReturnSource

1 year

≈−92%

Screener; ScanX (−92.48%)

3-year CAGR

≈−5%

Screener

5-year CAGR

≈−22%

Screener

Since IPO (≈₹27)

≈+30%

Derived (₹35 vs ≈₹27)

Valuation Multiples

MultipleAnand RayonsBasisPeer range (Value Research)

P/E (reported TTM)

7.05x

Screener, on pre-tax quarterly sum

15.9x–91.2x

P/E (normalised TTM)

≈9.5x

Derived: ₹76.7 Cr ÷ (₹10.87 Cr × (1−0.255))

—

P/E (FY2026 reported PAT)

≈10.6x

Derived: ₹76.7 Cr ÷ ₹7.25 Cr

—

P/B

0.74x

Screener (book value ₹47.6)

2.1x–2.9x

EV/EBITDA (TTM)

≈7.2x

Derived: EV ≈₹78.7 Cr (mcap + net debt ₹1.95 Cr) ÷ TTM operating profit ₹11.14 Cr

—

EV/Sales (TTM)

≈0.17x

Derived: ₹78.7 Cr ÷ ₹453 Cr

—

Dividend yield

0%

Screener

—

Dividend History

Fiscal yearDPS (INR)Payout (%)

FY2019

≈0.50 (derived from 24% payout on EPS ₹2.08; paid Sep 2019)

24

FY2020–FY2026

00

Capital Markets

ItemStatus

Buyback authorisations

None ever

Credit ratings (Moody's / S&P / Fitch)

Not rated

Domestic bank-loan ratings (CRISIL / ICRA / CARE / India Ratings)

None identified in sources reviewed

Listed debt / NCDs

None (Reg. 57(5) non-applicability confirmed 3 Apr 2026)

Debt maturity profile

Not publicly disclosed; borrowings of ₹36 Cr (March 2026) presumed short-term working-capital lines

Equity share-capital trajectory

₹14.98 Cr (2019) → ≈₹21.9 Cr (2026, derived) via warrant conversions; authorised capital to increase by ₹10 Cr (approved by board 31 Aug 2026)

Analyst Conclusions

Management guidance and consensus

Management guidance: none published.

Consensus estimates: none (zero coverage).

Run-rate indicator: H1-equivalent trailing data show revenue of ₹453 Cr TTM (to June 2026) and Q1 FY2027 growth of 26% YoY. If the company merely holds the TTM run-rate with FY2026 margins, FY2027 revenue would be ≈₹450–460 Cr and PAT ≈₹8 Cr (illustrative arithmetic, not a forecast).

Bull case (grounded in data)

  1. Cheap on assets and earnings: P/B 0.74x against book value of ₹47.6, with ≈₹34 Cr of cash (implied) and near-zero net debt; normalised P/E ≈9.5x versus textile peers at 16–91x.

  2. Demonstrated operating leverage from new capital: FY2026 revenue +38% and PAT +109%; Q3 FY2026 proved a ₹127 Cr quarterly revenue capacity at 3.8% OPM; five straight quarters of YoY growth.

  3. Insider alignment improving: promoters bought shares on the open market in September–October 2026, lifting Anand Bakshi's stake to 27.47% and promoter group to 53.60%, while the warrant overhang has been extinguished (lapse of 19.38 lakh warrants).

Bear case (grounded in data)

  1. Profit quality is weak: FY2026 CFO of −₹11 Cr; debtor days 73 and rising; ≈24% of FY2026 PBT came from other income rather than trading.

  2. Structural return ceiling: OPM stuck at ~2–2.5% for six years; ROE ~8% even after doubling profit — below cost of equity for a micro-cap.

  3. Disclosure and governance risk: BSE discrepancy notice and revised results (Aug 2025), revised FY2026 audited results, rescheduled results meeting, undisclosed economics of food/oil/foil diversification, combined Chair/MD, and an authorised-capital increase that could signal further dilution.

Catalysts and monitorables (next 12 months)

Catalyst / monitorableExpected timingWhat to watch
Q2 FY2027 resultsBy mid-Nov 2026Revenue vs ₹112.25 Cr base; OPM; sequential recovery from Q1
H1 FY2027 balance sheetNov 2026Receivables, cash, borrowings; CFO direction
Use of ₹10 Cr authorised-capital headroomAny timeAny new preferential issue, pricing, allottees
Food (Chhabee Nutricos) and petrochemical/foil revenue disclosureFY2027 annual report (~Aug 2027)Whether diversification is material or cosmetic
Q3 FY2027 resultsFeb 2027Comparison against record Q3 FY2026 (₹4.50 Cr PBT)
FY2027 audited resultsMay 2027Full-year tax normalisation, CSR applicability, dividend decision
Promoter tradingOngoingContinued buying vs selling/pledging
Exchange surveillance statusOngoingASM/GSM inclusion affecting liquidity

Concluding analyst verdict

Anand Rayons is, at its core, a small and competent Surat yarn trader that has been temporarily mistaken by the market for something else — first for a high-growth diversification story worth more than ₹800 Cr, and now, perhaps, for a business whose numbers cannot be trusted at all. The truth, as best the public record allows, lies between. The operating facts are genuinely improved: FY2026 revenue of ₹433 Cr and net profit of ₹7.25 Cr are records; leverage has fallen from roughly 1x to 0.35x; and interest coverage exceeds 5x. These gains are, however, largely a function of fresh equity rather than a better business: operating margins remain at ~2.3%, return on equity sits near 8%, and growth consumed ₹11 Cr of operating cash as receivables ballooned.

At ₹35, the market capitalisation of roughly ₹77 Cr sits below book value and around 9–10x normalised earnings — a valuation that already discounts a no-growth, thin-margin trader. That makes the downside from here primarily a function of balance-sheet quality, specifically the collectability of ≈₹87 Cr of trade receivables, rather than of earnings multiples. The upside requires evidence that FY2026's volume gains are durable, that cash flow turns positive, and that management stops announcing unquantified diversifications.

Governance signals are mixed: promoter buying and the extinguished warrant overhang are constructive, but a BSE-flagged results discrepancy, revised filings, a rescheduled results meeting, and a newly expanded authorised capital argue for caution. With no analyst coverage, no guidance and no investor communication, information asymmetry is extreme.

Verdict: a speculative, deep-value special situation. The Q2 FY2027 balance sheet (cash flow and debtor days) is the single most important near-term datapoint; absent improvement there, the low multiple is justified.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleDINTenureBackground / notesSource

Anand Gokulbhai Bakshi

Chairman & Managing Director; Promoter

01,942,639

CMD since 20 Sep 2018; partner in predecessor firm since 1992; re-appointed MD for 2 years (31 Aug 2026)

Founder-promoter; age ≈51–52 (Simply Wall St/MarketScreener)

BSE filings; Simply Wall St

Shilpa Anand Bakshi

Whole-time Director; Promoter group

07,986,896

Director since 2018; re-appointed WTD for 2 years (31 Aug 2026)

Promoter-family member; only woman director identified

BSE filings

Pankesh Patel

Non-Executive Independent Director

09,494,163

Appointed Additional ID 15 Feb 2022; re-appointed for second 5-year term (31 Aug 2026)

Background not disclosed in sources reviewed

BSE filing 15 Feb 2022; JKBFSL

Anil Navinchandra Merchant

Non-Executive Independent Director

09,414,010

Appointed ~2021–22; re-appointed for second 5-year term (31 Aug 2026)

Background not disclosed in sources reviewed

BSE filings; JKBFSL

Nileshkumar Mangaldas Bodiwala

Non-Executive Independent Director

08,465,357

Since 29 May 2019 (≈7 years)

Background not disclosed in sources reviewed

FY2019 AR; Blinkx

Executive Leadership Team

NameTitleTenureNotes

Anand Bakshi

CEO equivalent (CMD)

Since Sep 2018

Total compensation ≈₹2.4 million (≈US$27k) per Simply Wall St (latest fiscal year available to that source); salary/bonus/stock split not disclosed in sources reviewed

Varsha Maheshwari

Company Secretary & Compliance Officer

Since ~2021 (board considered CS appointment 5 May 2021; MarketScreener lists compliance officer since 5 May 2021, age 31)

Signs BSE filings

CFO

Chief Financial Officer

Since 1 Oct 2018 (MarketScreener)

Name not confirmed in sources reviewed

Governance Overview

AttributeAssessment

Board size

5

Independent directors

3 of 5 (60%)

Executive directors

2 (both promoter family)

Women directors

1 (Shilpa Bakshi — executive, promoter group)

Chair/CEO separation

No — combined Chairman & Managing Director

Committees

Audit Committee, Nomination & Remuneration Committee, Stakeholders' Relationship Committee (statutory under Companies Act 2013/SEBI LODR); committee reconstitution disclosed Feb 2022 with Anand Bakshi as member of at least two committees. Current chairs not confirmed in sources reviewed

Average board tenure

≈5.1 years (Simply Wall St)

Board & Management Changes

DateChangeContext

15 Feb 2022

Pankesh Patel appointed Additional Independent Director; committees reconstituted after a director's resignation

BSE filing

5 Aug 2025

Appointment of secretarial auditor approved alongside Q1 FY2026 results

ScanX

22 May 2026

Internal auditor Sutarwala & Associates re-appointed for FY2027

FY2026 results outcome

31 Aug 2026

Re-appointments: Anil Merchant and Pankesh Patel (IDs, second 5-year term); Anand Bakshi (MD, 2 years); Shilpa Bakshi (WTD, 2 years)

JKBFSL corporate news

Shareholding Trend

Holder categoryMar 2024Mar 2025Jun 2025Mar 2026Sep 2026

Promoters & promoter group (%)

70.7258.2251.5352.5753.60

Public (%)

29.2841.7848.4647.4346.41

FIIs (%)

00000

DIIs / mutual funds (%)

00000

Number of shareholders

6,2094,8874,6715,5995,985

Major Shareholders

HolderStakeAs ofSource

Anand Gokulbhai Bakshi (promoter)

27.47%

30 Sep 2026 (after open-market purchase of 10,377 shares for ₹3.64 lakh)

BSE PIT disclosure, 2 Oct 2026

Anand Gokulbhai Bakshi (earlier)

26.64% (57,18,652 shares)

H1 CY2026

Bajaj Finserv

Shilpa Anand Bakshi (promoter group)

5.96% (12,78,564 shares)

H1 CY2026

Bajaj Finserv

Anand Bakshi HUF (promoter group)

0.58% (1,24,000 shares)

H1 CY2026

Bajaj Finserv

Other promoter-group members

≈19–20% combined (individual names not confirmed in sources reviewed)

Sep 2026 (derived: 53.60% less named holdings)

Derived

Institutional investors

None (0% FII, 0% DII)

Sep 2026

Screener; Sharpely

Competitive Landscape

Key Competitors

#CompetitorCategoryRelevanceComparative scale
1

Nitin Spinners Ltd

Listed yarn & fabric manufacturer

Value Research peer

Revenue ₹3,296 Cr

2

Sangam (India) Ltd

Listed yarn & fabric manufacturer (synthetic/blended yarn)

Value Research peer

Revenue ₹3,305 Cr

3

Ganesha Ecosphere Ltd

Listed recycled-polyester fibre/yarn maker

Value Research peer

Revenue ₹1,568 Cr

4

AYM Syntex Ltd

Listed polyester/nylon filament yarn maker

Value Research peer

Revenue ₹1,390 Cr

5

Amarjothi Spinning Mills Ltd

Listed spinner

Zerodha-named competitor

—
6

Filatex India Ltd

Listed polyester/nylon filament yarn producer

Historical supplier; direct-sales competitor

—
7

Indo Rama Synthetics (India) Ltd

Listed polyester producer

Historical supplier; direct-sales competitor

—
8

Reliance Industries (polyester business)

Integrated polyester yarn producer

Largest Indian polyester yarn supplier; sells via distributors/directly

Not segment-comparable

9

Garden Silk Mills

Surat polyester yarn producer

Historical supplier

—
10

Unlisted Surat yarn traders and mill-authorised dealers

Private

Primary day-to-day competition for customers and dealership allocations

—

“—” = not publicly disclosed.

Peer Comparison FY2026

MetricAnand RayonsNitin SpinnersSangam (India)Ganesha EcosphereAYM Syntex

Market cap (INR Cr)

793,3583,1582,7361,712

Revenue TTM (INR Cr)

4533,2963,3051,5681,390

Net profit TTM (INR Cr)

10.87211.83121.5056.6018.77

Net margin (%)

2.396.423.673.571.34

RoE (%)

10.9414.9212.054.453.23

P/E (x)

7.2415.8525.9948.4391.24

P/B (x)

0.762.172.832.102.90

R&D intensity (% of revenue)

0 disclosed

————

Recent Developments

At some point the stock was placed under BSE's Additional Surveillance Measure (Long-Term ASM Stage I) per Sharpely; the date is not confirmed, and by January 2026 Choice India showed the stock under "no framework".

Company Snapshot

$50M

Revenue

1987

Founded

Surat, India

Headquarters

SWOT Analysis

Strengths

  • Record scale and profitability: FY2026 revenue ₹432.96 Cr (+38%) and PAT ₹7.25 Cr (+109%) — both all-time highs (BSE, 22 May 2026)
  • De-levered balance sheet: Debt/equity fell from 1.03x (FY2023) to 0.35x (FY2026); net debt only ₹1.95 Cr at March 2026
  • Strong interest coverage: EBIT/interest improved to 5.2x in FY2026 from 2.0x in FY2022 (derived from Screener)
  • Consistent profitability through cycles: Profitable in every reported year since FY2019, including COVID-hit FY2021 (Screener)
  • Long operating history and niche expertise: Trading since 1987; historical dealerships from JCT, Indorama, Garden Silk, Filatex (DRHP)
  • Clean audit and governance basics: Unmodified statutory audit opinion on FY2026; 60% independent board
  • Asset-light model: Fixed assets ≈₹1 Cr; asset turnover 3.4–4.6x

Weaknesses

  • Wafer-thin margins: OPM 1.2%–3.8% quarterly; FY2026 OPM 2.3%; net margin 1.67%
  • Deteriorating working capital: Debtor days 44 → 73 (FY2024→FY2026); payable days 8 → 3; CCC 77 days
  • Negative operating cash flow in growth year: FY2026 CFO −₹11 Cr; FCF −₹14 Cr despite record profit
  • Low structural returns: 3-year average ROE ≈7.7% (Screener); FY2025 ROE 6.2%
  • Dependence on non-operating income: Other income ₹2.37 Cr = ≈24% of FY2026 PBT
  • Disclosure gaps and errors: BSE discrepancy notice on Q1 FY2026 results (Aug 2025) requiring revision; FY2026 results board meeting rescheduled; revised audited results filed
  • Single-segment, single-country concentration: 100% domestic textile trading revenue

Opportunities

  • Deploy fresh equity into higher volumes: Net worth ₹102 Cr vs ₹36 Cr two years earlier; revenue capacity demonstrated by Q3 FY2026 run-rate of ₹127 Cr/quarter
  • Diversification into adjacent B2B commodities: Petrochemical oils and aluminium foil already disclosed (AR FY2024)
  • Food-sector partnership: 5-year Chhabee Nutricos agreement (Aug 2025)
  • Export of chemicals: Stated plan in AR FY2024; currently zero export revenue
  • Valuation re-rating potential: P/B 0.74 and normalised P/E ≈9.5x vs textile peers at 16–91x P/E (Value Research)
  • Continued textile demand recovery: Five consecutive quarters of YoY revenue growth through Q1 FY2027

Threats

  • Customer credit risk in fragmented MSME base: ≈₹87 Cr receivables at March 2026 (derived: 73 days on ₹433 Cr) vs net worth ₹102 Cr
  • Equity-market confidence collapse: Share price −92% over 1 year; 52-week low ₹33 on 6 Oct 2026
  • Failure of warrant programme to complete: 19,38,334 warrants lapsed, ₹3.78 Cr forfeited (28 Sep 2026) — ≈₹15 Cr of expected capital not received (derived)
  • Yarn-price volatility: FY2025 revenue −8.9%; quarterly OPM swings of 1.2%–3.8%
  • Possible further dilution: Authorised capital raised by ₹10 Cr (31 Aug 2026)
  • Disintermediation by producers / competition from unlisted traders: Structural feature of the trading layer; no moat

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
12 May 2025Board meeting held (agenda per BSE record)Routine
24 May 2025Board meeting outcome filed (warrant-related)Equity build continues
26 May 2025FY2025 audited results: revenue ₹313.75 Cr (−8.9%), PAT ₹3.47 Cr (+11%), EPS ₹1.89Profit resilience despite revenue decline
9 Jun 2025Conversion of 1,76,666 warrants at ₹78; paid-up capital ≈₹21.0 CrDilution; capital inflow
Jun 2025 quarterPromoter holding falls to 51.53%Lowest promoter stake since listing
23 Jul 2025Board approves further conversion of warrants into sharesCapital inflow
5 Aug 2025Q1 FY2026 results (revenue ₹75.95 Cr, +8%; PAT ₹1.18 Cr, +125%); secretarial auditor appointedReturn to growth
8–14 Aug 2025BSE issues discrepancy notice on Q1 results; company files revised Q1 FY2026 resultsDisclosure-quality flag
11 Aug 2025AGM held; board meeting on AGM mattersRoutine
~23 Aug 2025Five-year partnership with Chhabee Nutricos Inds LLP — food-sector entryDiversification; stock momentum period
Sep 2025Market cap ≈₹794 Cr (Choice India, 9 Sep 2025)Valuation at ~100x+ P/E
10 Nov 2025Q2 FY2026: revenue ₹112.25 Cr (+35%); PAT ₹1.50 Cr; EBITDA margin 1.22% vs 2.44%Growth at lower margin
Late 2025 – Jan 2026Stock reaches 52-week high ₹470 (exact date not confirmed); ₹388 on 20 Jan 2026 with market cap ≈₹828 CrPeak speculative valuation
23 Dec 2025Trading window closure ahead of Q3 resultsRoutine
17 Jan 2026Allotment of shares on warrant conversion (Reg. 30)Capital inflow
28 Jan 2026Board meeting intimation for 5 Feb 2026Routine
5 Feb 2026Q3 FY2026: revenue ₹126.66 Cr (+70%), PAT ₹4.50 Cr (+454%)Best quarter in company history
11 Feb 2026Stock at ₹208 (market cap ≈₹471 Cr)Sell-off under way despite results
6 Mar 2026Stock at ₹91.95; −62% in one month, −76% in three months (Simply Wall St)Collapse
2 Apr 2026Stock at ₹63.43; P/E 14.5, P/B 1.46 (ICICIdirect)Valuation de-rating
3 Apr 2026Disclosure of non-applicability of LODR Reg. 57(5) (no non-convertible securities)Confirms no listed debt
6 Apr 2026Reg. 74(5) compliance certificate for Q4 FY2026Routine
11 Apr 2026Confirmation of non-applicability of SEBI large-corporate debt circularNot a "large corporate" borrower
4–5 May 2026Board meeting for FY2026 results fixed for 15 May, then rescheduled to 22 May 2026Delay noted by market commentators
22 May 2026FY2026 audited results: income ₹435.34 Cr, PAT ₹7.25 Cr (+109%), EPS ₹3.36; unmodified audit opinion; revised results also filed same dayRecord year
1 Jun 2026Stock at ₹47.72Continued decline
20 Jul 2026Allotment of shares on conversion of warrantsFinal conversion tranche
11 Aug 2026Q1 FY2027: revenue ₹95.58 Cr (+26%), PBT/PAT ₹2.32 Cr (+97%); stock ₹43.01Growth continues, decelerating
31 Aug 2026Authorised capital +₹10 Cr; IDs re-appointed (5 yrs); MD and WTD re-appointed (2 yrs)Possible future equity issuance
28 Sep 202619,38,334 warrants lapse; ₹3.78 Cr forfeited; trading window closed for Q2 FY2027Warrant holders declined to convert at ₹78 with stock ≈₹38
30 Sep – 2 Oct 2026Promoter open-market purchases; Anand Bakshi's stake rises to 27.47%Insider buying signal
1–6 Oct 2026Stock makes successive 52-week lows: ₹34.5 (1 Oct), ₹34 (5 Oct), ₹33 (6 Oct) — eight straight down sessions≈93% below peak
12 Oct 2026Reg. 74(5) certificate for quarter ended 30 Sep 2026Routine
Pending (expected by mid-Nov 2026)Q2 FY2027 resultsNext catalyst

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

2 charts
Revenue by Region: India revenue rose from INR 3,442.6 Mn in FY2024 to INR 4,329.6 Mn in FY2026.
Anand Rayons Limited — Revenue by Region
Series (INR Mn)FY2024FY2025FY2026
India revenue3,442.63,137.54,329.6

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. BSE Limited — Anand Rayons Ltd (scrip 542721) corporate announcements, financial results and annual reports FY2019–FY2026 (bseindia.com)
  2. Screener.in — Anand Rayons Ltd (financials, ratios, shareholding, announcement digests) (screener.in)
  3. ScanX (Dhan) — FY2026 results digest (22 May 2026) (scanx.trade)
  4. ScanX — Q2 FY2026 results digest (10 Nov 2025) (scanx.trade)
  5. ScanX — Chhabee Nutricos partnership and revised Q1 FY2026 results (scanx.trade)
  6. ScanX — Q3 FY2026 results digest (scanx.trade)
  7. Univest — Q1 FY2027 results (univest.in)
  8. Value Research — stock page and peer comparison · valueresearchonline.com
  9. IIFL — company summary (DRHP-derived history) (indiainfoline.com)
  10. IIFL — board meeting record (warrant allotment) (live-next.indiainfoline.com)
  11. Simply Wall St — company information, management, price history (simplywall.st)
  12. MarketsMojo — 52-week-low reports (Oct 2026) (marketsmojo.com)
  13. MarketsMojo (Motilal Oswal) — capital structure, ISIN (marketsmojo.motilaloswal.com)
  14. FinancialFilings.com — LEI, FY2026 headline figures (financialfilings.com)
  15. RegisterKaro — MCA data (CIN, capital, charges) (registerkaro.in)
  16. JKBFSL — 31 Aug 2026 board outcome (jkbfsl.com)
  17. BSE filing — board reconstitution, 15 Feb 2022 (bseindia.com)
  18. BSE — Annual Report FY2019 (bseindia.com)
  19. Zerodha — net debt, Reuters headlines (zerodha.com)
  20. Bajaj Finserv — promoter shareholding detail (bajajfinserv.in)
  21. Zonebourse / MarketScreener — business description, management ages (in.marketscreener.com)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.